(UroToday.com) At the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, during the session entitled “Breaking Barriers: Ensuring Equity in Cancer Diagnosis, Treatment, and Trial Enrollment for Patients with Kidney and Bladder Cancers,” Dr. Ravindran Kanesvaran presented on how we may optimize care, including clinical trial enrollments for older patients with kidney and bladder cancer.